<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="gata1" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">gata1</book-part-id>
      <title-group>
        <title><italic toggle="yes">GATA1</italic>-Related X-Linked Cytopenia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chou</surname>
            <given-names>Stella T</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Assistant Professor, Pediatrics<break/>University of Pennsylvania School of Medicine <break/>Division of Hematology <break/>The Children's Hospital of Philadelphia <break/>Philadelphia, Pennsylvania</aff>
          <email>chous@email.chop.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kacena</surname>
            <given-names>Melissa A</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Associate Professor, Department of Orthopaedic Surgery<break/>Indiana University School of Medicine<break/>Indianapolis, Indiana</aff>
          <email>mkacena@iupui.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Weiss</surname>
            <given-names>Mitchell J</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Professor, Pediatrics <break/>Department of Hematology<break/>St Jude Children&#x02019;s Research Hospital <break/>Memphis, Tennessee</aff>
          <email>mitch.weiss@stjude.org</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Raskind</surname>
            <given-names>Wendy H</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Professor, Departments of Medicine and Psychiatry and Behavioral Sciences <break/>University of Washington Medical Center<break/>Seattle, Washington</aff>
          <email>wendyrun@uw.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>22</day>
          <month>11</month>
          <year>2006</year>
        </date>
        <date date-type="updated">
          <day>11</day>
          <month>5</month>
          <year>2017</year>
        </date>
        <date date-type="revised">
          <day>30</day>
          <month>3</month>
          <year>2007</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="cmt2d" document-type="chapter"><italic toggle="yes">GARS</italic>-Associated Axonal Neuropathy</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="cmt-4a" document-type="chapter"><italic toggle="yes">GDAP1</italic>-Related Hereditary Motor and Sensory Neuropathy</related-object>
      <abstract id="gata1.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">GATA1</italic>-related cytopenia is characterized by thrombocytopenia and/or anemia ranging from mild to severe. One or more of the following may also be present: platelet dysfunction, mild &#x003b2;-thalassemia, neutropenia, and congenital erythropoietic porphyria (CEP) in males. Thrombocytopenia typically presents in infancy as a bleeding disorder with easy bruising and mucosal bleeding (e.g., epistaxis). Anemia ranges from minimal (mild dyserythropoiesis) to severe (hydrops fetalis requiring in utero transfusion). At the extreme end of the clinical spectrum, severe hemorrhage and/or erythrocyte transfusion dependence are life long; at the milder end, anemia and the risk for bleeding may decrease spontaneously with age. Heterozygous females may have mild to moderate symptoms such as menorrhagia.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Diagnostic laboratory findings usually include macrothrombocytopenia (low number of platelets that are larger than normal) and/or anemia with red cell indices that may be micro-, normo- or macrocytic. Defects in platelet aggregation in response to agonists may be seen. In some cases electron microscopy reveals reduced numbers of platelet alpha granules and dysplastic features in platelets and megakaryocytes.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations</italic>: Platelet transfusions for moderate to severe epistaxis, gingival bleeding, or gastrointestinal bleeding; no specific treatment for mild symptoms (easy bruisability); erythrocyte transfusions when anemia is symptomatic (fatigue, tachycardia).</p>
          <p><italic toggle="yes">Prevention of primary manifestations</italic>: For severe cases, bone marrow transplantation (BMT) can be curative.</p>
          <p><italic toggle="yes">Surveillance</italic>: Monitoring complete blood counts (with frequency depending on disease severity) to inform supportive care; monitoring those undergoing repeated erythrocyte transfusions for iron overload.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid</italic>: Those with thrombocytopenia should avoid antiplatelet agents including aspirin and nonsteroidal anti-inflammatory agents (e.g., ibuprofen). Those with thrombocytopenia and/or platelet aggregation defects should avoid contact sports or activities with a high risk of trauma.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk</italic>: If a <italic toggle="yes">GATA1</italic> pathogenic variant has been identified in the family, complete blood counts and molecular genetic testing of at-risk relatives can be offered. At-risk relatives who choose not to have molecular genetic testing should have complete blood counts to evaluate for thrombocytopenia, anemia, or neutropenia.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">GATA1</italic>-related cytopenia is inherited in an X-linked manner. If the mother of an affected male has a <italic toggle="yes">GATA1</italic> pathogenic variant, the chance of transmitting it in each pregnancy is 50%. Affected males pass the pathogenic variant to all of their daughters and none of their sons. Testing for at-risk family members and prenatal testing for pregnancies at increased risk are possible once the pathogenic variant has been identified in the family.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="gata1.Diagnosis">
        <title>Diagnosis</title>
        <sec id="gata1.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p><italic toggle="yes">GATA1</italic>-related cytopenia <bold>should be suspected</bold> in an individual with the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Thrombocytopenia and/or anemia ranging from mild to severe (including fetal hydrops)</p>
            </list-item>
            <list-item>
              <p>One or more of the following:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Platelet dysfunction</p>
                </list-item>
                <list-item>
                  <p>Mild &#x003b2;-thalassemia</p>
                </list-item>
                <list-item>
                  <p>Neutropenia</p>
                </list-item>
                <list-item>
                  <p><related-object link-type="booklink" source-id="gene" document-id="cep" document-type="chapter">Congenital erythropoietic porphyria</related-object> (CEP)</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Family history consistent with X-linked inheritance</p>
            </list-item>
            <list-item>
              <p>No evidence of <related-object link-type="booklink" source-id="gene" document-id="was" document-type="chapter">Wiskott-Aldrich syndrome</related-object> (WAS), an X-linked disorder of microthrombocytopenia that can present with or without immunodeficiency</p>
            </list-item>
          </list>
          <p>Note: 1) Initial testing should include complete blood count, examination of the blood smear, and bone marrow aspirate and biopsy to confirm that cytopenia results from ineffective hematopoiesis rather than peripheral destruction or sequestration. 2) Hematologic findings in <italic toggle="yes">GATA1</italic>-related cytopenia are variable and usually nonspecific (i.e., seen in numerous conditions and thus by themselves not indicative of a specific diagnosis). 3) Affected individuals are typically male; females will usually present with milder findings.</p>
        </sec>
        <sec id="gata1.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p><bold>Male proband.</bold> The diagnosis of <italic toggle="yes">GATA1</italic>-related cytopenia <bold>is established</bold> in a male proband with cytopenia resulting from ineffective hematopoiesis by identification of a hemizygous pathogenic variant in <italic toggle="yes">GATA1</italic> by molecular genetic testing (see <xref ref-type="table" rid="gata1.T.molecular_genetic_testing_used_i">Table 1</xref>).</p>
          <p><bold>Female proband.</bold> The diagnosis of <italic toggle="yes">GATA1</italic>-related cytopenia <bold>may be established</bold> in a female proband with hematopoietic cytopenias by identification of a pathogenic variant in <italic toggle="yes">GATA1</italic> by molecular genetic testing (<xref ref-type="table" rid="gata1.T.molecular_genetic_testing_used_i">Table 1</xref>). A pattern of skewed X-inactivation would support the diagnosis. Note: This disorder is not usually first diagnosed in a family via a female proband.</p>
          <p>Molecular testing approaches can include <bold>single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">GATA1</italic> is performed. Although no exon or whole-gene deletions or duplications have been reported as a cause of <italic toggle="yes">GATA1</italic>-related cytopenias, some laboratories offer gene-targeted deletion/duplication analysis if a pathogenic variant is not found.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">GATA1</italic> and other genes of interest (see <xref ref-type="sec" rid="gata1.Differential_Diagnosis">Differential Diagnosis</xref>) may be considered. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost while limiting secondary findings. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
              <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing and genome sequencing may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="gata1.T.molecular_genetic_testing_used_i" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in <italic toggle="yes">GATA1</italic>-Related Cytopenia</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_gata1.T.molecular_genetic_testing_used_i_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_gata1.T.molecular_genetic_testing_used_i_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_gata1.T.molecular_genetic_testing_used_i_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_gata1.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">GATA1</italic>
                  </td>
                  <td headers="hd_h_gata1.T.molecular_genetic_testing_used_i_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3,&#x000a0;4</sup></td>
                  <td headers="hd_h_gata1.T.molecular_genetic_testing_used_i_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">22/22&#x000a0;<sup>5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_gata1.T.molecular_genetic_testing_used_i_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_gata1.T.molecular_genetic_testing_used_i_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>7</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="gata1.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="gata1" object-id="gata1.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="gata1.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="gata1.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="gata1.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="gata1.TF.1.4">
                <label>4. </label>
                <p>Lack of amplification by PCR prior to sequence analysis can suggest a putative (multi)exon or whole-gene deletion on the X chromosome in affected males; confirmation requires additional testing by gene-targeted deletion/duplication analysis.</p>
              </fn>
              <fn id="gata1.TF.1.5">
                <label>5. </label>
                <p><xref ref-type="bibr" rid="gata1.REF.nichols.2000.266">Nichols et al [2000]</xref>, <xref ref-type="bibr" rid="gata1.REF.mehaffey.2001.2681">Mehaffey et al [2001]</xref>, <xref ref-type="bibr" rid="gata1.REF.freson.2002.147">Freson et al [2002]</xref>, <xref ref-type="bibr" rid="gata1.REF.yu.2002.2040">Yu et al [2002]</xref>, <xref ref-type="bibr" rid="gata1.REF.balduini.2004.129">Balduini et al [2004]</xref>, <xref ref-type="bibr" rid="gata1.REF.del_vecchio.2005.113">Del Vecchio et al [2005]</xref>, <xref ref-type="bibr" rid="gata1.REF.hughan.2005.4369">Hughan et al [2005]</xref>, <xref ref-type="bibr" rid="gata1.REF.hollanda.2006.807">Hollanda et al [2006]</xref>, <xref ref-type="bibr" rid="gata1.REF.phillips.2007.2618">Phillips et al [2007]</xref>, <xref ref-type="bibr" rid="gata1.REF.sankaran.2012.2439">Sankaran et al [2012]</xref>, <xref ref-type="bibr" rid="gata1.REF.klar.2014.949">Klar et al [2014]</xref>, <xref ref-type="bibr" rid="gata1.REF.parrella.2014.1319">Parrella et al [2014]</xref>, &#x001fa;str&#x000f6;m et al [2015], <xref ref-type="bibr" rid="gata1.REF.di_pierro.2015.491">Di Pierro et al [2015]</xref>, <xref ref-type="bibr" rid="gata1.REF.zucker.2016.917">Zucker et al [2016]</xref></p>
              </fn>
              <fn id="gata1.TF.1.6">
                <label>6. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single exon deletions or duplications.</p>
              </fn>
              <fn id="gata1.TF.1.7">
                <label>7. </label>
                <p>No data on detection rate of gene-targeted deletion/duplication analysis are available.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="gata1.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="gata1.Clinical_Description">
          <title>Clinical Description</title>
          <p>Individuals with <italic toggle="yes">GATA1</italic>-related cytopenia have thrombocytopenia and/or anemia.</p>
          <p>
            <bold>Males</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Males typically present in infancy with a bleeding disorder:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Affected individuals have easy bruising and mucosal bleeding (e.g., epistaxis).</p>
                </list-item>
                <list-item>
                  <p>Physical examination may reveal petechiae, ecchymoses, or splenomegaly.</p>
                </list-item>
                <list-item>
                  <p>Excessive hemorrhage and/or bruising can occur either spontaneously or after trauma or surgery.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Anemia, the other major clinical problem in males with this disorder, ranges from minimal with only mild dyserythropoiesis [<xref ref-type="bibr" rid="gata1.REF.freson.2001.85">Freson et al 2001</xref>] to severe hydrops fetalis requiring in utero transfusions [<xref ref-type="bibr" rid="gata1.REF.nichols.2000.266">Nichols et al 2000</xref>].</p>
              <list list-type="bullet">
                <list-item>
                  <p>Anemia can be so severe that affected males are red blood cell transfusion dependent from birth [<xref ref-type="bibr" rid="gata1.REF.freson.2002.147">Freson et al 2002</xref>].</p>
                </list-item>
                <list-item>
                  <p>In one family, moderately severe anemia was associated with <related-object link-type="booklink" source-id="gene" document-id="cep" document-type="chapter">congenital erythropoietic porphyria</related-object> (CEP) with no pathogenic variants detected in <italic toggle="yes">UROS</italic>; an Arg216Trp pathogenic variant was identified in <italic toggle="yes">GATA1</italic> [<xref ref-type="bibr" rid="gata1.REF.phillips.2007.2618">Phillips et al 2007</xref>]. The affected individual also had bullous skin lesions associated with porphyria. In two additional probands with CEP, anemia and thrombocytopenia, a pathogenic variant in <italic toggle="yes">UROS</italic> or <italic toggle="yes">SEC23B</italic> was detected in addition to an Arg216Trp variant in <italic toggle="yes">GATA1</italic> [<xref ref-type="bibr" rid="gata1.REF.di_pierro.2015.491">Di Pierro et al 2015</xref>].</p>
                </list-item>
                <list-item>
                  <p>Variable mild to moderate neutropenia with macrocytic anemia and normal platelet counts has been reported in association with a germline pathogenic variant resulting in a truncated protein (GATA-1s; discussed in <xref ref-type="sec" rid="gata1.Molecular_Genetics">Molecular Genetics</xref>, <bold>Pathogenic variants</bold>) [<xref ref-type="bibr" rid="gata1.REF.hollanda.2006.807">Hollanda et al 2006</xref>, <xref ref-type="bibr" rid="gata1.REF.sankaran.2012.2439">Sankaran et al 2012</xref>, <xref ref-type="bibr" rid="gata1.REF.zucker.2016.917">Zucker et al 2016</xref>]; family members with severe neutropenia were predisposed to infection [<xref ref-type="bibr" rid="gata1.REF.hollanda.2006.807">Hollanda et al 2006</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Splenomegaly is commonly present in one form of <italic toggle="yes">GATA1</italic>-related disease (see <xref ref-type="sec" rid="gata1.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>). Typically, no other physical anomalies are present.</p>
            </list-item>
          </list>
          <p>
            <bold>Laboratory findings in males</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Complete blood count showing the following:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Platelet counts are usually low (10-100 x 10<sup>3</sup>/&#x000b5;L), but vary considerably with specific pathogenic variants. Normal counts have also been reported (150-400 x 10<sup>3</sup>/&#x000b5;L), including individuals with a germline pathogenic variant resulting in a truncated protein (GATA-1s; see <xref ref-type="sec" rid="gata1.Molecular_Genetics">Molecular Genetics</xref>, <bold>Pathogenic variants</bold>) causing congenital anemia [<xref ref-type="bibr" rid="gata1.REF.hollanda.2006.807">Hollanda et al 2006</xref>, <xref ref-type="bibr" rid="gata1.REF.sankaran.2012.2439">Sankaran et al 2012</xref>]. The platelets are typically larger than normal (macrothrombocytopenia).</p>
                </list-item>
                <list-item>
                  <p>Anemia (hematocrit 16%-35%; normal: 35%-45%) may be present; the severity varies with the specific pathogenic variant. Red cell indices are normochromic but may be mildly microcytic (75-79 fL) or macrocytic (101-103 fL) (normal: 80-99 fL).</p>
                </list-item>
                <list-item>
                  <p>Significant persistent neutropenia (0.5-2.8 x 10<sup>3</sup>/&#x000b5;L; normal 1.9-8.0 x 10<sup>3</sup>/&#x000b5;L) was observed in one family with a specific <italic toggle="yes">GATA1</italic> pathogenic variant [<xref ref-type="bibr" rid="gata1.REF.hollanda.2006.807">Hollanda et al 2006</xref>]; findings were variable in families with other <italic toggle="yes">GATA1</italic> variants [<xref ref-type="bibr" rid="gata1.REF.sankaran.2012.2439">Sankaran et al 2012</xref>, <xref ref-type="bibr" rid="gata1.REF.zucker.2016.917">Zucker et al 2016</xref>].</p>
                </list-item>
              </list>
              <p>Note: Thrombocytopenia, anemia, and neutropenia are usually defined as two standard deviations below values observed in the normal population.</p>
            </list-item>
            <list-item>
              <p>Peripheral blood smear that may show the following:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Some platelets that are larger and more spherical than the typical discoid morphology. Platelets may be pale, reflecting reduced granularity.</p>
                </list-item>
                <list-item>
                  <p>Variation in erythrocyte size and shape and hypochromia, reflecting low hemoglobin content</p>
                </list-item>
                <list-item>
                  <p>Decreased neutrophils with abnormal morphology; this rare finding was reported in one family with an unusual germline pathogenic variant resulting in a truncated protein (GATA-1s; discussed in <xref ref-type="sec" rid="gata1.Molecular_Genetics">Molecular Genetics</xref>, <bold>Pathogenic variants</bold>) [<xref ref-type="bibr" rid="gata1.REF.hollanda.2006.807">Hollanda et al 2006</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Bone marrow biopsy that may show the following:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Hyper- or hypocellularity</p>
                </list-item>
                <list-item>
                  <p>Increased or decreased numbers of megakaryocytes</p>
                </list-item>
                <list-item>
                  <p>Small, dysplastic megakaryocytes with signs of incomplete maturation</p>
                </list-item>
                <list-item>
                  <p>Dyserythropoiesis</p>
                </list-item>
                <list-item>
                  <p>Hypocellularity of erythroid and granulocytic lineages</p>
                </list-item>
                <list-item>
                  <p>Mild to moderate reticulin fibrosis [<xref ref-type="bibr" rid="gata1.REF._str_m.2015.e44">&#x000c5;str&#x000f6;m et al 2015</xref>]</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Platelet function abnormalities. Defects in platelet aggregation in response to agonists (e.g., ristocetin, adenosine diphosphate, epinephrine, or collagen) occur in some cases [<xref ref-type="bibr" rid="gata1.REF.thompson.1977.303">Thompson et al 1977</xref>, <xref ref-type="bibr" rid="gata1.REF.freson.2001.85">Freson et al 2001</xref>, <xref ref-type="bibr" rid="gata1.REF.balduini.2004.129">Balduini et al 2004</xref>, <xref ref-type="bibr" rid="gata1.REF.hollanda.2006.807">Hollanda et al 2006</xref>]. These studies can be normal in some affected individuals.</p>
            </list-item>
            <list-item>
              <p>Electron microscopy. Findings in some cases include reduced numbers of platelet alpha granules and dysplastic features in megakaryocytes and platelets.</p>
            </list-item>
            <list-item>
              <p>In subtypes associated with globin chain imbalance, findings consistent with mild hemolysis, including mild reticulocytosis, elevated LDH, and low haptoglobin, may be present. In addition, HbA2 and HbF may be elevated.<table-wrap id="gata1.Tc" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><tbody><tr><td valign="middle" align="left" rowspan="1" colspan="1"><bold>Definitions of terms used to describe this disorder</bold><p><bold>Thrombocytopenia.</bold> Reduced platelet count</p><p><bold>Macrothrombocytopenia.</bold> Thrombocytopenia with large platelets</p><p><bold>Dyserythropoiesis.</bold> Impaired production and maturation of erythrocytes (red blood cells)</p><p><bold>Thalassemia.</bold> An inherited form of anemia associated with unbalanced globin chain synthesis</p><p><bold>Hemoglobin.</bold> The oxygen-carrying compound of red blood cells, made up of heme, &#x003b1;-globin, and &#x003b2;-globin. &#x003b2;-thalassemia is associated with decreased &#x003b2;-globin synthesis in red blood cells.</p></td></tr></tbody></table></table-wrap>
</p>
            </list-item>
          </list>
          <p><bold>Findings in heterozygous females.</bold> Females may manifest platelet abnormalities [<xref ref-type="bibr" rid="gata1.REF.white.2007.620">White 2007</xref>] and mild to moderate symptoms such as menorrhagia or easy bruising, presumably related to the proportion of relevant cells that contain the pathogenic <italic toggle="yes">GATA1</italic> variant on the active X chromosome [<xref ref-type="bibr" rid="gata1.REF.nichols.2000.266">Nichols et al 2000</xref>; <xref ref-type="bibr" rid="gata1.REF.raskind.2000.2262">Raskind et al 2000</xref>; <xref ref-type="bibr" rid="gata1.REF.balduini.2004.129">Balduini et al 2004</xref>; <xref ref-type="bibr" rid="gata1.REF.del_vecchio.2005.113">Del Vecchio et al 2005</xref>; Raskind, unpublished observations].</p>
          <list list-type="bullet">
            <list-item>
              <p>Platelet counts may be normal or mildly to moderately decreased [<xref ref-type="bibr" rid="gata1.REF.nichols.2000.266">Nichols et al 2000</xref>]; this may depend on the nature of the pathogenic variant or other (either genetic or environmental) modifiers.</p>
            </list-item>
            <list-item>
              <p>Morphologic abnormalities of platelets can be detected by electron microscopy [<xref ref-type="bibr" rid="gata1.REF.white.2007.620">White 2007</xref>] and in some instances on peripheral blood smears [<xref ref-type="bibr" rid="gata1.REF.tubman.2007.3297">Tubman et al 2007</xref>].</p>
            </list-item>
            <list-item>
              <p>Two distinct platelet morphologies can be observed on peripheral blood smear, reflecting mosaicism secondary to random X-chromosome inactivation.</p>
            </list-item>
          </list>
          <p><bold>Course and prognosis</bold>. The long-term course in both males and females depends on disease severity:</p>
          <list list-type="bullet">
            <list-item>
              <p>At the extreme end of the clinical spectrum, severe hemorrhage and/or erythrocyte transfusion dependence are life long.</p>
            </list-item>
            <list-item>
              <p>At the milder end, the risk for bleeding may spontaneously decrease with age, despite continued thrombocytopenia [<xref ref-type="bibr" rid="gata1.REF.mehaffey.2001.2681">Mehaffey et al 2001</xref>, <xref ref-type="bibr" rid="gata1.REF.del_vecchio.2005.113">Del Vecchio et al 2005</xref>].</p>
            </list-item>
            <list-item>
              <p>Some affected individuals may be recognized only after incidental findings of mild to moderate cytopenias on blood count analysis. These individuals have a good prognosis.</p>
            </list-item>
          </list>
        </sec>
        <sec id="gata1.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p><xref ref-type="table" rid="gata1.T.genotypephenotype_correlations">Table 2</xref> outlines the relationship between specific <italic toggle="yes">GATA1</italic> pathogenic variants and associated phenotypic features.</p>
          <table-wrap id="gata1.T.genotypephenotype_correlations" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Genotype-Phenotype Correlations</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Pathogenic Variant&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Platelet Phenotype&#x000a0;<sup>2</sup></th>
                  <th id="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Platelet Aggregation</th>
                  <th id="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Red Cell Phenotype</th>
                  <th id="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Other Features</th>
                  <th id="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" valign="middle" align="left" scope="col" rowspan="1" colspan="1">References</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="table" rid="gata1.T.gata1_pathogenic_variants_discus">p.Val205Met</xref>
                  </td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x02193;<break/>Large</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Not studied</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x02193;<break/>Dyserythropoietic, fetal hydrops</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Cryptorchidism&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="gata1.REF.nichols.2000.266">Nichols et al [2000]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="table" rid="gata1.T.gata1_pathogenic_variants_discus">p.Gly208Ser</xref>
                  </td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x02193;<break/>Large</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Decreased</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Normal</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="gata1.REF.mehaffey.2001.2681">Mehaffey et al [2001]</xref>&#x000a0;<sup>4,&#x000a0;5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="table" rid="gata1.T.gata1_pathogenic_variants_discus">p.Gly208Arg</xref>
                  </td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x02193;&#x02193;<break/>Large</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Not studied</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x02193;<break/>Dyserythropoietic</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Cryptorchidism in proband but also in 2 sibs with wild type <italic toggle="yes">GATA1</italic>&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="gata1.REF.del_vecchio.2005.113">Del Vecchio et al [2005]</xref>, <xref ref-type="bibr" rid="gata1.REF.kratz.2008.432">Kratz et al [2008]</xref>&#x000a0;<sup>4,&#x000a0;5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="table" rid="gata1.T.gata1_pathogenic_variants_discus">p.Arg216Gln</xref>
                  </td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x02193;<break/>Large</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Normal, but prolonged bleeding time</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Mild &#x003b2;-thalassemia, mild anemia</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Splenomegaly</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="gata1.REF.thompson.1977.303">Thompson et al [1977]</xref>, <xref ref-type="bibr" rid="gata1.REF.raskind.2000.2262">Raskind et al [2000]</xref>, <xref ref-type="bibr" rid="gata1.REF.yu.2002.2040">Yu et al [2002]</xref>, <xref ref-type="bibr" rid="gata1.REF.balduini.2004.129">Balduini et al [2004]</xref>, <xref ref-type="bibr" rid="gata1.REF.hughan.2005.4369">Hughan et al [2005]</xref>, <xref ref-type="bibr" rid="gata1.REF.tubman.2007.3297">Tubman et al [2007]</xref>, <xref ref-type="bibr" rid="gata1.REF.campbell.2013.5218">Campbell et al [2013]</xref>, &#x001fa;str&#x000f6;m et al [2015]</td>
                </tr>
                <tr>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="table" rid="gata1.T.gata1_pathogenic_variants_discus">p.Arg216Trp</xref>
                  </td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x02193;</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Not reported</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Mild &#x003b2;-thalassemia</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Congenital erythropoietic porphyria, splenomegaly</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="gata1.REF.hindmarsh.1986.1255">Hindmarsh [1986]</xref>, <xref ref-type="bibr" rid="gata1.REF.phillips.2007.2618">Phillips et al [2007]</xref>, <xref ref-type="bibr" rid="gata1.REF.ged.2009.53">Ged et al [2009]</xref>, <xref ref-type="bibr" rid="gata1.REF.campbell.2013.5218">Campbell et al [2013]</xref></td>
                </tr>
                <tr>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="table" rid="gata1.T.gata1_pathogenic_variants_discus">p.Asp218Gly</xref>
                  </td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x02193;<break/>Large</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Decreased</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Dyserythropoiesis without anemia</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="gata1.REF.freson.2001.85">Freson et al [2001]</xref>, <xref ref-type="bibr" rid="gata1.REF.white.2007.620">White [2007]</xref>, <xref ref-type="bibr" rid="gata1.REF.white.2007.436">White et al [2007]</xref></td>
                </tr>
                <tr>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="table" rid="gata1.T.gata1_pathogenic_variants_discus">p.Asp218Tyr</xref>
                  </td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x02193;&#x02193;<break/>Large</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Not studied</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Severe anemia</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Platelets in carrier female expressed only wild type allele</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="gata1.REF.freson.2002.147">Freson et al [2002]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="table" rid="gata1.T.gata1_pathogenic_variants_discus">p.Ter414ArgextTer42</xref>
                  </td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x02193;<break/>Large</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Not studied</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Normal</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Lu(a-b-) red cells</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="gata1.REF.singleton.2013.139">Singleton et al [2013]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="table" rid="gata1.T.gata1_pathogenic_variants_discus">332G&#x0003e;C</xref>
                  </td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Normal counts, but dysplastic megakaryocytes</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Decreased</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Macrocytic anemia of variable severity</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Neutropenia</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="gata1.REF.hollanda.2006.807">Hollanda et al [2006]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="table" rid="gata1.T.gata1_pathogenic_variants_discus">p.Val74Leu</xref>
                  </td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Normal or &#x02193;</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Not studied</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Macrocytic anemia of variable severity</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="gata1.REF.sankaran.2012.2439">Sankaran et al [2012]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="table" rid="gata1.T.gata1_pathogenic_variants_discus">c.220+1delG</xref>
                  </td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Normal</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Not studied</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Anemia</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="gata1.REF.sankaran.2012.2439">Sankaran et al [2012]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="table" rid="gata1.T.gata1_pathogenic_variants_discus">c.220G&#x0003e;C</xref>
                  </td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Normal</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Not studied</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Macrocytic anemia</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="gata1.REF.klar.2014.949">Klar et al [2014]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <xref ref-type="table" rid="gata1.T.gata1_pathogenic_variants_discus">p.Met1_Cys83del</xref>
                  </td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x02193;</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Not studied</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Anemia</td>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="gata1.REF.parrella.2014.1319">Parrella et al [2014]</xref>
                  </td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="gata1.TF.2.1">
                <label>1. </label>
                <p>See <xref ref-type="table" rid="gata1.T.gata1_pathogenic_variants_discus">Table 4</xref> for details.</p>
              </fn>
              <fn id="gata1.TF.2.2">
                <label>2. </label>
                <p>Decreased platelet alpha granules are observed in all affected males studied.</p>
              </fn>
              <fn id="gata1.TF.2.3">
                <label>3. </label>
                <p>Cryptorchidism has been reported in several males with <italic toggle="yes">GATA1</italic> pathogenic variants [<xref ref-type="bibr" rid="gata1.REF.nichols.2000.266">Nichols et al 2000</xref>, <xref ref-type="bibr" rid="gata1.REF.del_vecchio.2005.113">Del Vecchio et al 2005</xref>]. Although <italic toggle="yes">Gata1</italic> is expressed in mouse testis, knockout of <italic toggle="yes">Gata1</italic> in Sertoli cells within the testis had no effect, suggesting that <italic toggle="yes">Gata1</italic> is not essential for Sertoli cell function [<xref ref-type="bibr" rid="gata1.REF.lindeboom.2003.5405">Lindeboom et al 2003</xref>]. The independent segregation of cryptorchidism and <italic toggle="yes">GATA1</italic> pathogenic variants in one of the two families [<xref ref-type="bibr" rid="gata1.REF.del_vecchio.2005.113">Del Vecchio et al 2005</xref>], in conjunction with the mouse data, make the mechanistic relationship between <italic toggle="yes">GATA1</italic> pathogenic variants and cryptorchidism unclear at this point.</p>
              </fn>
              <fn id="gata1.TF.2.4">
                <label>4. </label>
                <p>No response to splenectomy and/or steroids</p>
              </fn>
              <fn id="gata1.TF.2.5">
                <label>5. </label>
                <p>Decreased bleeding episodes with age, despite persistence of thrombocytopenia</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>For further information on murine and in vitro experiments involving GATA-1, see <xref ref-type="sec" rid="gata1.Molecular_Genetics">Molecular Genetics</xref>, <bold>Pathogenic variants</bold>.</p>
        </sec>
        <sec id="gata1.Nomenclature">
          <title>Nomenclature</title>
          <p>Until pathogenic variants in <italic toggle="yes">GATA1</italic> were shown to underlie this heterogeneous disorder, a variety of terms were coined for the different clinical presentations. The first term used was X-linked thrombocytopenia with thalassemia (XLTT) [<xref ref-type="bibr" rid="gata1.REF.raskind.2000.2262">Raskind et al 2000</xref>]. Other terms used in the past and still in the current literature are &#x02018;familial dyserythropoietic anemia and thrombocytopenia&#x02019; [<xref ref-type="bibr" rid="gata1.REF.nichols.2000.266">Nichols et al 2000</xref>, <xref ref-type="bibr" rid="gata1.REF.del_vecchio.2005.113">Del Vecchio et al 2005</xref>] and &#x02018;X-linked macrothrombocytopenia&#x02019; [<xref ref-type="bibr" rid="gata1.REF.freson.2001.85">Freson et al 2001</xref>].</p>
          <p>To describe individuals with a clinical diagnosis of <related-object link-type="booklink" source-id="gene" document-id="diamond-b" document-type="chapter">Diamond-Blackfan anemia</related-object> in whom <italic toggle="yes">GATA1</italic> pathogenic variants are identified and ribosomal protein variants are absent, the authors suggest the phrase &#x02018;variant DBA associated with pathogenic variant of <italic toggle="yes">GATA1</italic>.&#x02019;</p>
        </sec>
        <sec id="gata1.Prevalence">
          <title>Prevalence</title>
          <p><italic toggle="yes">GATA1</italic>-related cytopenia is rare; the prevalence is not known. To date, hematopoietic disease caused by inherited pathogenic variants in <italic toggle="yes">GATA1</italic> has been reported in 22 families [<xref ref-type="bibr" rid="gata1.REF.nichols.2000.266">Nichols et al 2000</xref>, <xref ref-type="bibr" rid="gata1.REF.freson.2001.85">Freson et al 2001</xref>, <xref ref-type="bibr" rid="gata1.REF.mehaffey.2001.2681">Mehaffey et al 2001</xref>, <xref ref-type="bibr" rid="gata1.REF.freson.2002.147">Freson et al 2002</xref>, <xref ref-type="bibr" rid="gata1.REF.yu.2002.2040">Yu et al 2002</xref>, <xref ref-type="bibr" rid="gata1.REF.balduini.2004.129">Balduini et al 2004</xref>, <xref ref-type="bibr" rid="gata1.REF.del_vecchio.2005.113">Del Vecchio et al 2005</xref>, <xref ref-type="bibr" rid="gata1.REF.hughan.2005.4369">Hughan et al 2005</xref>, <xref ref-type="bibr" rid="gata1.REF.phillips.2005.515a">Phillips et al 2005</xref>, <xref ref-type="bibr" rid="gata1.REF.hollanda.2006.807">Hollanda et al 2006</xref>, <xref ref-type="bibr" rid="gata1.REF.sankaran.2012.2439">Sankaran et al 2012</xref>, <xref ref-type="bibr" rid="gata1.REF.singleton.2013.139">Singleton et al 2013</xref>, <xref ref-type="bibr" rid="gata1.REF.hermans.2014.305">Hermans et al 2014</xref>, <xref ref-type="bibr" rid="gata1.REF.klar.2014.949">Klar et al 2014</xref>, <xref ref-type="bibr" rid="gata1.REF.parrella.2014.1319">Parrella et al 2014</xref>, <xref ref-type="bibr" rid="gata1.REF._str_m.2015.e44">&#x000c5;str&#x000f6;m et al 2015</xref>, <xref ref-type="bibr" rid="gata1.REF.di_pierro.2015.491">Di Pierro et al 2015</xref>, <xref ref-type="bibr" rid="gata1.REF.zucker.2016.917">Zucker et al 2016</xref>].</p>
          <p><italic toggle="yes">GATA1</italic> pathogenic variants may be more common than previously appreciated, particularly in persons with mild, unexplained thrombocytopenia/&#x02018;gray platelet syndrome&#x02019; present since birth [<xref ref-type="bibr" rid="gata1.REF.tubman.2007.3297">Tubman et al 2007</xref>] or individuals with congenital hypoplastic anemia/Diamond-Blackfan anemia with no ribosomal protein pathogenic variants [<xref ref-type="bibr" rid="gata1.REF.sankaran.2012.2439">Sankaran et al 2012</xref>].</p>
        </sec>
      </sec>
      <sec id="gata1.Genetically_Related_Allelic_Disord">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold>&#x02018;Gray platelet syndrome&#x02019; (GPS)</bold> is a term that has been used to describe a genetically heterogeneous group of congenital disorders in which the platelets are large and have a gray appearance on light microscopy (Wright-stained slides) and the platelet alpha granules are either absent or reduced in numbers on electron microscopy. One family with a <xref ref-type="table" rid="gata1.T.gata1_pathogenic_variants_discus">c.647G&#x0003e;A</xref> pathogenic variant in <italic toggle="yes">GATA1</italic> was reported to have GPS [<xref ref-type="bibr" rid="gata1.REF.tubman.2007.3297">Tubman et al 2007</xref>]; however, in general, GPS is not associated with <italic toggle="yes">GATA1</italic> (see <xref ref-type="sec" rid="gata1.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="diamond-b" document-type="chapter"><bold>Diamond Blackfan anemia</bold></related-object>
<bold>(DBA)</bold> in its classic form is characterized by a profound normochromic and usually macrocytic anemia with normal leukocytes and platelets, congenital malformations in up to 50% of affected individuals, and growth restriction in 30%. DBA has been associated with pathogenic variants in more than ten ribosomal protein (RP)-encoding genes. In several unrelated DBA probands with no pathogenic variant detected in any of the RP-encoding genes, affected individuals harbor pathogenic frameshift or nonsense variants in <italic toggle="yes">GATA1</italic> that result in the exclusive production of an amino terminal truncated protein termed &#x02018;GATA-1 short&#x02019; (GATA-1s) [<xref ref-type="bibr" rid="gata1.REF.sankaran.2012.2439">Sankaran et al 2012</xref>, <xref ref-type="bibr" rid="gata1.REF.klar.2014.949">Klar et al 2014</xref>, <xref ref-type="bibr" rid="gata1.REF.parrella.2014.1319">Parrella et al 2014</xref>, <xref ref-type="bibr" rid="gata1.REF.zucker.2016.917">Zucker et al 2016</xref>]. Thus, GATA-1s-producing pathogenic variants result in a phenocopy of DBA that is not associated with growth restriction or congenital abnormalities occurring with pathogenic variants in any of the RP-encoding genes (see <xref ref-type="sec" rid="gata1.Nomenclature">Nomenclature</xref>).</p>
      </sec>
      <sec id="gata1.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><italic toggle="yes">GATA1</italic>-related cytopenia must be distinguished from other acquired and inherited thrombocytopenias and platelet function abnormalities [<xref ref-type="bibr" rid="gata1.REF.balduini.2004.513">Balduini &#x00026; Savoia 2004</xref>, <xref ref-type="bibr" rid="gata1.REF.drachman.2004.390">Drachman 2004</xref>] (see <xref ref-type="table" rid="gata1.T.etiology_and_characteristics_of">Table 3</xref>). Algorithms exist to help differentiate among these disorders [<xref ref-type="bibr" rid="gata1.REF.drachman.2004.390">Drachman 2004</xref>, <xref ref-type="bibr" rid="gata1.REF.noris.2004.1219">Noris et al 2004</xref>].</p>
        <p>Because of its X-linked mode of inheritance and association with thrombocytopenia, <related-object link-type="booklink" source-id="gene" document-id="was" document-type="chapter">Wiskott-Aldrich syndrome</related-object> (WAS) can be confused with <italic toggle="yes">GATA1</italic>-related cytopenia. Distinguishing features of WAS include small platelets, eczema (~80%), and immunodeficiency, although individuals with milder pathogenic variants may manifest with microthrombocytopenia only.</p>
        <p>In <italic toggle="yes">GATA1</italic>-related cytopenia, platelets are usually large and may be hypogranular. Relatively common congenital causes of <bold>macrothrombocytopenia</bold> that could potentially be confused with <italic toggle="yes">GATA1</italic>-related disorders are described in <xref ref-type="table" rid="gata1.T.etiology_and_characteristics_of">Table 3</xref>.</p>
        <table-wrap id="gata1.T.etiology_and_characteristics_of" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p>Etiology and Characteristics of Other Inherited Syndromes of Macrothrombocytopenia</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Name</th>
                <th id="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene</th>
                <th id="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Mode of Inheritance</th>
                <th id="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Features</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Bernard-Soulier syndrome<break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/231200">231200</ext-link>)</td>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">GP1BA</italic>
                  <break/>
                  <italic toggle="yes">GP1BB</italic>
                  <break/>
                  <italic toggle="yes">GP9</italic>
                </td>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Severely defective ristocetin-induced platelet agglutination</p></list-item><list-item><p>Severe bleeding disorder</p></list-item></list>
</td>
              </tr>
              <tr>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="myh9" document-type="chapter"><italic toggle="yes">MYH9</italic>-related syndromes</related-object>
                </td>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">MYH9</italic>
                </td>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Neutrophil inclusions</p></list-item><list-item><p>Hearing loss, cataract, or renal defects variably present</p></list-item></list>
</td>
              </tr>
              <tr>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Mediterranean thrombocytopenia<break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/153670">153670</ext-link>)</td>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">GP1BA</italic>
                </td>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Dysmegakaryo-cytopoiesis</p></list-item></list>
</td>
              </tr>
              <tr>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Paris-Trousseau thrombocytopenia<break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/188025">188025</ext-link>)</td>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">See footnote 2</td>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">AD</td>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_4" rowspan="2" valign="middle" align="left" colspan="1"><list list-type="bullet"><list-item><p>Cardiac and facial abnormalities</p></list-item><list-item><p>Intellectual disability</p></list-item></list>
</td>
              </tr>
              <tr>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">Jacobsen syndrome<break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/147791">147791</ext-link>)</td>
              </tr>
              <tr>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="gr_22q11deletion" document-type="chapter">22q11.2 deletion syndrome</related-object>
                </td>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">See footnote 3</td>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Facial and cardiac abnormalities</p></list-item><list-item><p>Intellectual disability</p></list-item><list-item><p>Psychiatric disorders</p></list-item></list>
</td>
              </tr>
              <tr>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Gray platelet syndrome<break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/139090">139090</ext-link>)</td>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">NBEAL2</italic><break/><italic toggle="yes">GATA1</italic>&#x000a0;<sup>4</sup></td>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">See footnote 5</td>
                <td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Pale platelets</p></list-item><list-item><p>Reduced or absent &#x003b1;-granules</p></list-item></list>
</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="gata1.TF.3.1">
              <label>1. </label>
              <p>Heterozygotes may have mild disease.</p>
            </fn>
            <fn id="gata1.TF.3.2">
              <label>2. </label>
              <p>Paris-Trousseau thrombocytopenia and Jacobsen syndrome are contiguous gene deletion syndromes.</p>
            </fn>
            <fn id="gata1.TF.3.3">
              <label>3. </label>
              <p><related-object link-type="booklink" source-id="gene" document-id="gr_22q11deletion" document-type="chapter">22q11.2 deletion syndrome</related-object> is a contiguous gene deletion syndrome.</p>
            </fn>
            <fn id="gata1.TF.3.4">
              <label>4. </label>
              <p>One person with an X-linked form of this syndrome was found to have a <italic toggle="yes">GATA1</italic> pathogenic variant [<xref ref-type="bibr" rid="gata1.REF.wechsler.2002.148">Wechsler et al 2002</xref>, <xref ref-type="bibr" rid="gata1.REF.tubman.2007.3297">Tubman et al 2007</xref>] (see <xref ref-type="sec" rid="gata1.Genetically_Related_Allelic_Disord">Genetically Related Disorders</xref>).</p>
            </fn>
            <fn id="gata1.TF.3.5">
              <label>5. </label>
              <p>Most cases of GPS are simplex (i.e., a single occurrence in a family), but sibships with unaffected, often consanguineous parents consistent with an autosomal recessive mode of inheritance and families with apparent autosomal dominant or X-linked transmission have been reported [reviewed in <xref ref-type="bibr" rid="gata1.REF.nurden.2007.21">Nurden &#x00026; Nurden 2007</xref>].</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="gata1.Management">
        <title>Management</title>
        <sec id="gata1.Evaluations_Following_Initial_Diag">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with <italic toggle="yes">GATA1</italic>-related cytopenia, the following are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Complete blood count and examination of the peripheral smear to assess the degree of cytopenia(s)</p>
            </list-item>
            <list-item>
              <p>Detailed history of age at which hematologic disease was manifest</p>
            </list-item>
            <list-item>
              <p>Documentation of abnormal/unexpected bleeding episodes and platelet counts obtained at the time of the episodes to help determine whether platelet function is abnormal and whether disease severity has changed over time</p>
              <p>Note: Platelet aggregation studies may also be useful to identify functional abnormalities that predict a greater risk of bleeding for any given platelet count, but studies can be difficult to interpret when platelet counts are lower than 100,000/&#x003bc;L.</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="gata1.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Individuals with <italic toggle="yes">GATA1</italic>-related cytopenia are treated supportively.</p>
          <p><bold>Thrombocytopenia.</bold> Individuals with moderate to severe epistaxis, gingival bleeding, or gastrointestinal bleeding should receive platelet transfusions. Transfusion requirements vary from person to person as bleeding can be related to quantitative and/or qualitative platelet defects.</p>
          <list list-type="bullet">
            <list-item>
              <p>For individuals with thrombocytopenia and/or platelet aggregation defects, DDAVP treatment may be helpful for short-term management of mild to moderate bleeding.</p>
            </list-item>
            <list-item>
              <p>Individuals who are only mildly symptomatic (easy bruisability without mucosal or more severe bleeding) do not require specific treatment.</p>
            </list-item>
            <list-item>
              <p>There is no evidence that splenectomy is beneficial in people with <italic toggle="yes">GATA1</italic>-related disease, although this treatment may be considered if splenomegaly is severe. Although splenectomy may improve the cytopenias, platelet dysfunction will not be improved.</p>
            </list-item>
          </list>
          <p><bold>Anemia.</bold> Erythrocyte transfusions are indicated when anemia is symptomatic (fatigue, tachycardia).</p>
          <list list-type="bullet">
            <list-item>
              <p>Iron overload and the development of alloantibodies may limit chronic transfusion therapy.</p>
            </list-item>
            <list-item>
              <p>Extended pre-transfusion red blood cell phenotyping and matching for minor erythrocyte antigens in individuals receiving frequent transfusions can reduce the risk of alloimmunization.</p>
            </list-item>
          </list>
          <p><bold>Neutropenia.</bold> Individuals with neutropenia who present with fever should be evaluated promptly with a physical examination, complete blood count, and blood culture and should receive appropriate parenteral antibiotics.</p>
          <p><bold>Bone marrow transplantation (BMT).</bold> For severe cases, BMT can be curative [<xref ref-type="bibr" rid="gata1.REF.hollanda.2006.807">Hollanda et al 2006</xref>, <xref ref-type="bibr" rid="gata1.REF.phillips.2007.2618">Phillips et al 2007</xref>, <xref ref-type="bibr" rid="gata1.REF.parrella.2014.1319">Parrella et al 2014</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>BMT should be considered in individuals with severe phenotypes of <italic toggle="yes">GATA1</italic>-related cytopenia, particularly if an HLA-matched donor is available.</p>
            </list-item>
            <list-item>
              <p>While BMT may offer a cure, clinical experience with BMT in this disease is limited and families must be counseled on the significant risks and morbidity associated with BMT.</p>
            </list-item>
          </list>
        </sec>
        <sec id="gata1.Prevention_of_Primary_Manifestatio">
          <title>Prevention of Primary Manifestations</title>
          <p>The only definitive cure for <italic toggle="yes">GATA1</italic>-related cytopenia is bone marrow transplantation.</p>
        </sec>
        <sec id="gata1.Prevention_of_Secondary_Complicati">
          <title>Prevention of Secondary Complications</title>
          <p>Individuals with thrombocytopenia and/or platelet aggregation defects should receive a platelet transfusion prior to surgical or invasive dental procedures.</p>
          <p>Individuals with neutropenia should be counseled regarding their increased risk of infection. They should avoid crowds and contact with individuals who have communicable diseases. When febrile, those who are severely neutropenic (absolute neutrophil count &#x0003c;500/&#x000b5;L) should seek medical attention; typically blood cultures are obtained and parenteral antibiotics are administered to avoid the possibility of life-threatening sepsis.</p>
        </sec>
        <sec id="gata1.Surveillance">
          <title>Surveillance</title>
          <p>Depending on the phenotype of the disease, complete blood counts should be monitored so that supportive care can be provided as needed. Individuals with mild cytopenias require infrequent monitoring (yearly), while those with severe cytopenias who require transfusions should have complete blood counts monthly or as indicated by clinical signs and symptoms.</p>
          <p>Individuals undergoing repeated erythrocyte transfusions should be monitored for iron overload and managed appropriately with iron chelation therapy.</p>
        </sec>
        <sec id="gata1.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Individuals with thrombocytopenia should avoid antiplatelet agents including aspirin and nonsteroidal anti-inflammatory agents (e.g., ibuprofen).</p>
          <p>Individuals with thrombocytopenia and/or platelet aggregation defects should be advised to avoid contact sports or activities with a high risk of trauma.</p>
          <p>Individuals with significant neutropenia should avoid crowds and close contact with persons who have a communicable disease to minimize risk of infection.</p>
          <p>Individuals with significant splenomegaly should avoid contact sports, which involve increased risk for traumatic splenic rupture.</p>
        </sec>
        <sec id="gata1.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate apparently asymptomatic at-risk relatives of an affected individual in order to identify as early as possible those who would benefit from prompt initiation of treatment and preventive measures.</p>
          <p>Evaluations can include:</p>
          <list list-type="bullet">
            <list-item>
              <p>Molecular genetic testing for the familial <italic toggle="yes">GATA1</italic> pathogenic variant;</p>
            </list-item>
            <list-item>
              <p>A screening complete blood count to evaluate for thrombocytopenia, anemia, or neutropenia.</p>
              <p>Note: Platelet, erythrocyte, and neutrophil counts can vary significantly in individuals with <italic toggle="yes">GATA1</italic> pathogenic variants; normal results do not rule out the possibility that the relative has a <italic toggle="yes">GATA1</italic> pathogenic variant.</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="gata1.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="gata1.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
        <sec id="gata1.Other">
          <title>Other</title>
          <p>Unlike immune-mediated platelet disorders such as immune thrombocytopenic purpura, <italic toggle="yes">GATA1</italic>-related thrombocytopenia does not respond to steroid or immunoglobulin therapy.</p>
          <p>Supplemental erythropoietin therapy is unlikely to be effective because the anemia is secondary to ineffective erythropoiesis, not erythropoietin deficiency.</p>
        </sec>
      </sec>
      <sec id="gata1.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="gata1.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">GATA1</italic>-related cytopenia is inherited in an X-linked manner.</p>
        </sec>
        <sec id="gata1.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a male proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The father of an affected male will not have the disorder nor will he be hemizygous for the <italic toggle="yes">GATA1</italic> pathogenic variant; therefore, he does not require further evaluation/testing.</p>
            </list-item>
            <list-item>
              <p>In a family with more than one affected individual, the mother of an affected male is an obligate heterozygote (carrier). If a woman has more than one affected son and no other affected relatives and if the pathogenic variant cannot be detected in her leukocyte DNA, she has germline mosaicism (evidence of germline mosaicism has not been observed).</p>
            </list-item>
            <list-item>
              <p>If a male is the only affected family member (i.e., a simplex case), the mother may be a heterozygote (carrier) or the affected male may have a <italic toggle="yes">de novo</italic>
<italic toggle="yes">GATA1</italic> pathogenic variant, in which case the mother is not a carrier. Because very few families with <italic toggle="yes">GATA1</italic> pathogenic variants have been described to date, the frequency of <italic toggle="yes">de novo</italic> pathogenic variants is not known.</p>
            </list-item>
          </list>
          <p><bold>Sibs of a male proband.</bold> The risk to sibs depends on the genetic status of the mother:</p>
          <list list-type="bullet">
            <list-item>
              <p>If the mother of the proband has a <italic toggle="yes">GATA1</italic> pathogenic variant, the chance of transmitting it in each pregnancy is 50%.</p>
              <list list-type="bullet">
                <list-item>
                  <p>Males who inherit the pathogenic variant will be affected.</p>
                </list-item>
                <list-item>
                  <p>Females who inherit the pathogenic variant will be heterozygous and will usually not be affected, but may have reduced hematocrits and platelet counts to a variable degree. Large platelets may also be present and those with the globin chain imbalance subtype may have splenomegaly and slightly decreased &#x003b2;-globin synthesis.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>If the proband represents a simplex case (i.e., a single occurrence in a family) and if the <italic toggle="yes">GATA1</italic> pathogenic variant cannot be detected in the leukocyte DNA of the mother, the risk to sibs is slightly greater than that of the general population (though still &#x0003c;1%) because of the theoretic possibility of maternal germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Affected males transmit the <italic toggle="yes">GATA1</italic> pathogenic variant to:</p>
          <list list-type="bullet">
            <list-item>
              <p>All of their daughters, who will be carriers (heterozygotes) and will usually not be affected (see <xref ref-type="sec" rid="gata1.Clinical_Description">Clinical Description</xref>);</p>
            </list-item>
            <list-item>
              <p>None of their sons.</p>
            </list-item>
          </list>
          <p><bold>Other family members.</bold> The proband's maternal aunts may be at risk of being heterozygotes (carriers) for the pathogenic variant and the aunts&#x02019; offspring, depending on their gender, may be at risk of being heterozygotes (carriers) for the pathogenic variant or of being affected.</p>
        </sec>
        <sec id="gata1.Heterozygote_Carrier_Detection">
          <title>Heterozygote (Carrier) Detection</title>
          <p>Molecular genetic testing of at-risk female relatives to determine their genetic status is most informative if the pathogenic variant has been identified in the proband.</p>
          <p>Note: Females who are heterozygotes (carriers) for this X-linked disorder may develop clinical findings related to the disorder (see <xref ref-type="sec" rid="gata1.Clinical_Description">Clinical Description</xref>).</p>
        </sec>
        <sec id="gata1.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="gata1.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="gata1.Prenatal_Testing_and_Preimplantati">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">GATA1</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for <italic toggle="yes">GATA1</italic>-related cytopenia are possible.</p>
        </sec>
      </sec>
      <sec id="gata1.Resources">
        <title>Resources</title>
      </sec>
      <sec id="gata1.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">GATA1</italic> has six exons, although the first exon is non-coding and is not counted in some of the literature. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="gata1" object-id="gata1.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> Most germline <italic toggle="yes">GATA1</italic> variants associated with cytopenias are missense variants. These variants cluster in exon 4 amino acid residues 205, 208, 216, and 218 within the amino-terminal zinc finger domain. They either affect erythroid transcription factor (GATA-1) binding to DNA or interaction of GATA-1 with its essential cofactor, friend of GATA (FOG)-1 [<xref ref-type="bibr" rid="gata1.REF.nichols.2000.266">Nichols et al 2000</xref>, <xref ref-type="bibr" rid="gata1.REF.freson.2001.85">Freson et al 2001</xref>, <xref ref-type="bibr" rid="gata1.REF.mehaffey.2001.2681">Mehaffey et al 2001</xref>, <xref ref-type="bibr" rid="gata1.REF.freson.2002.147">Freson et al 2002</xref>, <xref ref-type="bibr" rid="gata1.REF.yu.2002.2040">Yu et al 2002</xref>, <xref ref-type="bibr" rid="gata1.REF.balduini.2004.129">Balduini et al 2004</xref>, <xref ref-type="bibr" rid="gata1.REF.del_vecchio.2005.113">Del Vecchio et al 2005</xref>].</p>
        <p>A pathogenic variant in exon 2 of <italic toggle="yes">GATA1</italic> that alters splicing was found in one family with anemia and neutropenia [<xref ref-type="bibr" rid="gata1.REF.hollanda.2006.807">Hollanda et al 2006</xref>]. Similar variants have been identified in several families with <related-object link-type="booklink" source-id="gene" document-id="diamond-b" document-type="chapter">Diamond-Blackfan anemia</related-object> without pathogenic ribosomal protein variants [<xref ref-type="bibr" rid="gata1.REF.sankaran.2012.2439">Sankaran et al 2012</xref>, <xref ref-type="bibr" rid="gata1.REF.parrella.2014.1319">Parrella et al 2014</xref>, <xref ref-type="bibr" rid="gata1.REF.klar.2014.949">Klar et al 2014</xref>, <xref ref-type="bibr" rid="gata1.REF.zucker.2016.917">Zucker et al 2016</xref>] and unpublished studies by several groups. These variants result in the exclusive production of an amino-truncated isoform of GATA-1, termed GATA-1s (for GATA-1 short; also discussed in <xref ref-type="sec" rid="gata1.Genetically_Related_Allelic_Disord">Genetically Related Disorders</xref>). In the context of Down syndrome (DS, trisomy 21), somatic variants resulting in the production of only GATA-1s are associated with leukemia and transient myeloproliferative disorder (TMD) [<xref ref-type="bibr" rid="gata1.REF.wechsler.2002.148">Wechsler et al 2002</xref>]; however, the same <italic toggle="yes">GATA1</italic> variants present in the germline of persons who do not have DS cause cytopenia but not leukemia [<xref ref-type="bibr" rid="gata1.REF.hollanda.2006.807">Hollanda et al 2006</xref>]. In mice, analogous variants increase the proliferative capacity of embryonic megakaryocyte precursors but produce a minimal hematopoietic phenotype in adults [<xref ref-type="bibr" rid="gata1.REF.li.2005.613">Li et al 2005</xref>].</p>
        <p><italic toggle="yes">Cis</italic> element variants affecting GATA-1 binding to target genes have also been implicated in red cell production or function. For example, Africans frequently carry a variant in the Duffy antigen/chemokine receptor (<italic toggle="yes">DARC</italic>) gene promoter that disrupts GATA-1 binding [<xref ref-type="bibr" rid="gata1.REF.tournamille.1995.224">Tournamille et al 1995</xref>]. This leads to the common African Duffy negative red cell phenotype, which confers resistance to <italic toggle="yes">Plasmodium vivax</italic> malaria.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="cep" document-type="chapter">Congenital erythropoietic porphyria</related-object> (CEP) can also be caused by variants in the promoter region of the gene encoding the heme synthetic enzyme uroporphyrinogen III synthase, where GATA-1 normally binds [<xref ref-type="bibr" rid="gata1.REF.solis.2001.753">Solis et al 2001</xref>].</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="sider-anemia" document-type="chapter">X-linked sideroblastic anemia</related-object> (XLSA) typically results from partial loss-of-function missense variants in the erythroid-specific heme biosynthesis protein 5-aminolevulinate synthase 2 (<italic toggle="yes">ALAS2</italic>). Variants in the GATA binding site located in a transcriptional enhancer element in <italic toggle="yes">ALAS2</italic> have been identified in several pedigrees with XLSA [<xref ref-type="bibr" rid="gata1.REF.campagna.2014.315">Campagna et al 2014</xref>, <xref ref-type="bibr" rid="gata1.REF.kaneko.2014.252">Kaneko et al 2014</xref>].</p>
        <p>As a master regulator of erythrocyte and megakaryocyte/platelet development, <italic toggle="yes">GATA1</italic> both activates and represses hundreds of genes in each of these lineages. Presumably, different missense variants in <italic toggle="yes">GATA1</italic> cause distinct phenotypes by altering the expression of specific subsets of target genes. These pathogenic variants could affect GATA1 DNA binding, interactions with cofactors, or both. Both of these properties of the GATA zinc fingers have been mapped by structural studies. However, recent analysis of <italic toggle="yes">GATA1</italic> pathogenic variants in murine complementation systems showed that structural studies and in vitro examination of purified recombinant proteins did not always accurately elucidate the effects of variants, and in vivo studies are required [<xref ref-type="bibr" rid="gata1.REF.campbell.2013.5218">Campbell et al 2013</xref>]. Specifically, p.Arg216Gln and p.Arg216Trp variants that impaired DNA binding in vitro did not measurably affect in vivo target gene occupancy. Instead, diminished TAL1 complex recruitment to GATA-1 target genes was implicated. Thus, establishing genotype-phenotype relationships in <italic toggle="yes">GATA1</italic>-associated anemias and thrombocytopenias presents a complex but worthwhile challenge that will likely elucidate general concepts of transcription factor function and human disease.</p>
        <table-wrap id="gata1.T.gata1_pathogenic_variants_discus" orientation="portrait" position="anchor">
          <label>Table 4. </label>
          <caption>
            <p><italic toggle="yes">GATA1</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                <th id="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2T&#x0003e;C</td>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Met1_Cys83del&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_3" rowspan="12" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_002049.3">NM_002049.3</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_002040.1">NP_002040.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.220G&#x0003e;C&#x000a0;<sup>3</sup></td>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val74Leu</td>
              </tr>
              <tr>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">c.220+1delG&#x000a0;<sup>4</sup></td>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.613G&#x0003e;A</td>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val205Met</td>
              </tr>
              <tr>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.622_623delGGinsTC<break/>(622_623GG&#x0003e;TC)</td>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly208Ser</td>
              </tr>
              <tr>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.622G&#x0003e;C</td>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly208Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.647G&#x0003e;A</td>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg216Gln&#x000a0;<sup>5</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.646C&#x0003e;T</td>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg216Trp</td>
              </tr>
              <tr>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">(332G&#x0003e;C)&#x000a0;<sup>6</sup></td>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.652G&#x0003e;T</td>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asp218Tyr</td>
              </tr>
              <tr>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.653A&#x0003e;G</td>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asp218Gly</td>
              </tr>
              <tr>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1240T&#x0003e;C</td>
                <td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ter414ArgextTer42&#x000a0;<sup>7</sup></td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn>
              <p>See <xref ref-type="table" rid="gata1.T.genotypephenotype_correlations">Table 2</xref> for genotype-phenotype correlations.</p>
            </fn>
            <fn id="gata1.TF.4.1">
              <label>1. </label>
              <p>Variant designation that does not conform to current naming conventions</p>
            </fn>
            <fn id="gata1.TF.4.2">
              <label>2. </label>
              <p>Obliterates initiation codon; alternative initiation Met84 residue is used, resulting in lack of full length cDNA [<xref ref-type="bibr" rid="gata1.REF.parrella.2014.1319">Parrella et al 2014</xref>].</p>
            </fn>
            <fn id="gata1.TF.4.3">
              <label>3. </label>
              <p>Alternation of the last nucleotide of exon 2; predicted to affect splicing [<xref ref-type="bibr" rid="gata1.REF.sankaran.2012.2439">Sankaran et al 2012</xref>]</p>
            </fn>
            <fn id="gata1.TF.4.4">
              <label>4. </label>
              <p>Exon skipping and frame shift are predicted because the deletion affects the canonic splice donor site [<xref ref-type="bibr" rid="gata1.REF.sankaran.2012.2439">Sankaran et al 2012</xref>].</p>
            </fn>
            <fn id="gata1.TF.4.5">
              <label>5. </label>
              <p>Also reported in one family with &#x02018;gray platelet syndrome&#x02019; (see <xref ref-type="sec" rid="gata1.Genetically_Related_Allelic_Disord">Genetically Related Disorders</xref>)</p>
            </fn>
            <fn id="gata1.TF.4.6">
              <label>6. </label>
              <p>Pathogenic variant alias reported in <xref ref-type="bibr" rid="gata1.REF.hollanda.2006.807">Hollanda et al [2006]</xref></p>
            </fn>
            <fn id="gata1.TF.4.7">
              <label>7. </label>
              <p>Pathogenic variant in stop codon 414 results in addition of 41 amino acids and use of new stop codon at residue 42 [<xref ref-type="bibr" rid="gata1.REF.singleton.2013.139">Singleton et al 2013</xref>].</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold>
<italic toggle="yes">GATA1</italic> encodes a nuclear protein of 413 amino acid residues that contains two zinc fingers and an acidic amino terminal domain that can function as a transcriptional activator [<xref ref-type="bibr" rid="gata1.REF.ferreira.2005.1215">Ferreira et al 2005</xref>, <xref ref-type="bibr" rid="gata1.REF.lowry.2006.6">Lowry &#x00026; Mackay 2006</xref>]. The C-terminal zinc finger is responsible for DNA binding activity for most or all target genes and the N-terminal zinc finger plays a role in stabilization of GATA-1 binding to DNA at a subset of target sites containing duplicated or palindromic GATA-1 motifs [<xref ref-type="bibr" rid="gata1.REF.ohneda.2002.237">Ohneda &#x00026; Yamamoto 2002</xref>]. The N-f is also critical for binding of GATA-1 to numerous partner proteins, including FOG1, an essential factor required for many GATA-1 functions [<xref ref-type="bibr" rid="gata1.REF.tsang.1997.109">Tsang et al 1997</xref>, <xref ref-type="bibr" rid="gata1.REF.fox.1999.2812">Fox et al 1999</xref>]. GATA-1 is expressed in hematopoietic lineages and in Sertoli cells of testis. Gene targeting studies in mice indicate that GATA-1 is essential for the development of erythrocyte, megakaryocyte, mast cell, and eosinophil lineages. It is not known whether individuals with inherited <italic toggle="yes">GATA1</italic> pathogenic variants have defects in the latter two cell lineages.</p>
        <p><bold>Abnormal gene product.</bold> All pathogenic variants are missense variants, indels, nonsense variants, or splice site substitutions resulting in the production of an abnormal protein. Missense variants in N-f affect its ability to bind either <italic toggle="yes">GATA1</italic> sites in DNA, the cofactor FOG1, or both. Splice site variants result in a short form of the protein, GATA-1s. Mice genetically engineered to express GATA-1s show prenatal anemia and megakaryocyte proliferation, but newborn and adult mice display no hematopoietic abnormalities [<xref ref-type="bibr" rid="gata1.REF.li.2005.613">Li et al 2005</xref>]. The functions of these abnormal proteins and their relationship to disease phenotypes are discussed in <xref ref-type="sec" rid="gata1.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref> and in <xref ref-type="table" rid="gata1.T.genotypephenotype_correlations">Table 2</xref>.</p>
        <sec id="gata1.Cancer_and_Benign_Tumors">
          <title>Cancer and Benign Tumors</title>
          <p>Two hematopoietic disorders in children with Down syndrome (DS) associated with acquired (somatic) pathogenic variants in exon 2 of <italic toggle="yes">GATA1</italic> are transient myeloproliferative disorder (TMD) and acute megakaryoblastic leukemia (M7 subtype, DS-AMKL) [<xref ref-type="bibr" rid="gata1.REF.wechsler.2002.148">Wechsler et al 2002</xref>, <xref ref-type="bibr" rid="gata1.REF.elagib.2003.4333">Elagib et al 2003</xref>, <xref ref-type="bibr" rid="gata1.REF.waltzer.2003.6516">Waltzer et al 2003</xref>, <xref ref-type="bibr" rid="gata1.REF.ahmed.2004.2480">Ahmed et al 2004</xref>, <xref ref-type="bibr" rid="gata1.REF.creutzig.2005.1355">Creutzig et al 2005</xref>, <xref ref-type="bibr" rid="gata1.REF.crispino.2005a.137">Crispino 2005a</xref>, <xref ref-type="bibr" rid="gata1.REF.crispino.2005b.40">Crispino 2005b</xref>, <xref ref-type="bibr" rid="gata1.REF.muntean.2006.986">Muntean et al 2006</xref>, <xref ref-type="bibr" rid="gata1.REF.roy.2009.3">Roy et al 2009</xref>, <xref ref-type="bibr" rid="gata1.REF.roberts.2013.3908">Roberts et al 2013</xref>].</p>
          <p>TMD, found in up to 10% of infants with DS, usually resolves spontaneously; however, TMD confers a markedly increased risk for DS-AMKL [<xref ref-type="bibr" rid="gata1.REF.wechsler.2002.148">Wechsler et al 2002</xref>, <xref ref-type="bibr" rid="gata1.REF.ahmed.2004.2480">Ahmed et al 2004</xref>, <xref ref-type="bibr" rid="gata1.REF.crispino.2005a.137">Crispino 2005a</xref>, <xref ref-type="bibr" rid="gata1.REF.crispino.2005b.40">Crispino 2005b</xref>, <xref ref-type="bibr" rid="gata1.REF.hitzler.2005.11">Hitzler &#x00026; Zipursky 2005</xref>]. The acquired exon 2 variants lead to premature arrest of translation and reinitiation of protein synthesis at the downstream methionine codon at position 83, and result in the production of GATA-1 short isoform (GATA-1s) that lacks the amino-terminal activation domain. Some splice site variants also result in generation of GATA-1s. Two novel <italic toggle="yes">GATA1</italic> variants involving internal deletions of either amino acids 77-199 or 74-88 were identified in six individuals with TMD [<xref ref-type="bibr" rid="gata1.REF.toki.2013.3181">Toki et al 2013</xref>]. How <italic toggle="yes">GATA1</italic> variants synergize with trisomy 21 to promote DS-AMKL is unknown.</p>
          <p>One individual with severe anemia and thrombocytopenia caused by a pathogenic missense variant in <italic toggle="yes">GATA1</italic> (p.Val205Met) developed myelodysplastic syndrome 18 years after a failed bone marrow transplantation. It is not clear whether the MDS with a clonal deletion of 20q was due to the underlying disease caused by the pathogenic variant of <italic toggle="yes">GATA1</italic>, bone marrow transplant associated toxicity, or both [Authors, unpublished data].</p>
        </sec>
      </sec>
      <sec id="gata1.References">
        <title>References</title>
        <sec id="gata1.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="gata1.Literature_Cited.reflist0">
            <ref id="gata1.REF.ahmed.2004.2480">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ahmed</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sternberg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Marcaigh</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wynn</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevens</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Addison</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vyas</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Natural history of GATA1 mutations in Down syndrome.</article-title>
                <source>Blood.</source>
                <volume>103</volume>
                <fpage>2480</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">14656875</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF._str_m.2015.e44">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>&#x000c5;str&#x000f6;m</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahn-Str&#x000f6;mberg</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zetterberg</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vedin</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merup</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmblad</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>X-linked thrombocytopenia with thalassemia displays bone marrow reticulin fibrosis and enhanced angiogenesis: comparisons with primary myelofibrosis.</article-title>
                <source>Am J Hematol.</source>
                <volume>90</volume>
                <fpage>E44</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">25421114</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.balduini.2004.129">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Balduini</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pecci</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loffredo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Izzo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noris</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grosso</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergamaschi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosti</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magrini</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ceresa</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conti</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poggi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savoia</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Effects of the R216Q mutation of GATA-1 on erythropoiesis and megakaryocytopoiesis.</article-title>
                <source>Thromb Haemost</source>
                <volume>91</volume>
                <fpage>129</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">14691578</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.balduini.2004.513">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Balduini</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savoia</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Inherited thrombocytopenias: molecular mechanisms.</article-title>
                <source>Semin Thromb Hemost</source>
                <volume>30</volume>
                <fpage>513</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">15497094</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.campagna.2014.315">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Campagna</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Bie</surname>
                    <given-names>CI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmitz-Abe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweeney</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sendamarai</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heeney</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yntema</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kannengiesser</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grandchamp</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niemeyer</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knoers</surname>
                    <given-names>NV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swart</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marron</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Wijk</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raymakers</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>May</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markianos</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bottomley</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swinkels</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleming</surname>
                    <given-names>MD</given-names>
                  </name>
                </person-group>
                <article-title>X-linked sideroblastic anemia due to ALAS2 intron 1 enhancer element GATA-binding site mutations.</article-title>
                <source>Am J Hematol.</source>
                <year>2014</year>
                <volume>89</volume>
                <fpage>315</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24166784</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.campbell.2013.5218">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilkinson-White</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthews</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blobel</surname>
                    <given-names>GA</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Analysis of disease-causing GATA1 mutations in murine gene complementation systems.</article-title>
                <source>Blood</source>
                <volume>121</volume>
                <fpage>5218</fpage>
                <lpage>27</lpage>
                <pub-id pub-id-type="pmid">23704091</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.creutzig.2005.1355">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Creutzig</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reinhardt</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diekamp</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dworzak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stary</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimmermann</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>AML Patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity.</article-title>
                <source>Leukemia</source>
                <volume>19</volume>
                <fpage>1355</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">15920490</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.crispino.2005a.137">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Crispino</surname>
                    <given-names>JD</given-names>
                  </name>
                </person-group>
                <year>2005a</year>
                <article-title>GATA1 in normal and malignant hematopoiesis.</article-title>
                <source>Semin Cell Dev Biol</source>
                <volume>16</volume>
                <fpage>137</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">15659348</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.crispino.2005b.40">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Crispino</surname>
                    <given-names>JD</given-names>
                  </name>
                </person-group>
                <year>2005b</year>
                <article-title>GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia.</article-title>
                <source>Pediatr Blood Cancer</source>
                <volume>44</volume>
                <fpage>40</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">15390312</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.del_vecchio.2005.113">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Del Vecchio</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giordani</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Santis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Mattia</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Dyserythropoietic anemia and thrombocytopenia due to a novel mutation in GATA-1.</article-title>
                <source>Acta Haematol</source>
                <volume>114</volume>
                <fpage>113</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16103636</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.di_pierro.2015.491">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Di Pierro</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karakas</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brancaleoni</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gambale</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurt</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winter</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Granata</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Czuchlewski</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Langella</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iolascon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cappellini</surname>
                    <given-names>MD</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Congenital erythropoietic porphyria linked to GATA1-R216W mutation: challenges for diagnosis.</article-title>
                <source>Eur J Haematol.</source>
                <volume>94</volume>
                <fpage>491</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">25251786</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.drachman.2004.390">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Drachman</surname>
                    <given-names>JG</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Inherited thrombocytopenia: when a low platelet count does not mean ITP.</article-title>
                <source>Blood</source>
                <volume>103</volume>
                <fpage>390</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14504084</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.elagib.2003.4333">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Elagib</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Racke</surname>
                    <given-names>FK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mogass</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khetawat</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delehanty</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldfarb</surname>
                    <given-names>AN</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation.</article-title>
                <source>Blood</source>
                <volume>101</volume>
                <fpage>4333</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">12576332</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.ferreira.2005.1215">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ferreira</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohneda</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philipsen</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>GATA1 function, a paradigm for transcription factors in hematopoiesis.</article-title>
                <source>Mol Cell Biol</source>
                <volume>25</volume>
                <fpage>1215</fpage>
                <lpage>27</lpage>
                <pub-id pub-id-type="pmid">15684376</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.fox.1999.2812">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liew</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmes</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kowalski</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crossley</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Transcriptional cofactors of the FOG family interact with GATA proteins by means of multiple zinc fingers.</article-title>
                <source>EMBO J</source>
                <volume>18</volume>
                <fpage>2812</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">10329627</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.freson.2001.85">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Freson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devriendt</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hoof</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vos</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thys</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minner</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoylaerts</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermylen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Geet</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation.</article-title>
                <source>Blood</source>
                <volume>98</volume>
                <fpage>85</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">11418466</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.freson.2002.147">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Freson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thys</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marien</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoylaerts</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermylen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Geet</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation.</article-title>
                <source>Hum Mol Genet</source>
                <volume>11</volume>
                <fpage>147</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">11809723</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.ged.2009.53">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ged</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moreau-Gaudry</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robert-Richard</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Verneuil</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Congenital erythropoietic porphyria: mutation update and correlations between genotype and phenotype.</article-title>
                <source>Cell Mol Biol (Noisy-le-grand)</source>
                <volume>55</volume>
                <fpage>53</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">19268002</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.hermans.2014.305">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hermans</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Waele</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Geet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freson</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Novel GATA1 mutation in residue D218 leads to macrothrombocytopenia and clinical bleeding problems.</article-title>
                <source>Platelets.</source>
                <volume>25</volume>
                <fpage>305</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">23971719</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.hindmarsh.1986.1255">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hindmarsh</surname>
                    <given-names>JT</given-names>
                  </name>
                </person-group>
                <year>1986</year>
                <article-title>The porphyrias: recent advances.</article-title>
                <source>Clin Chem.</source>
                <volume>32</volume>
                <fpage>1255</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">3521939</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.hitzler.2005.11">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hitzler</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zipursky</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Origins of leukaemia in children with Down syndrome.</article-title>
                <source>Nat Rev Cancer</source>
                <volume>5</volume>
                <fpage>11</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">15630411</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.hollanda.2006.807">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hollanda</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lima</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cunha</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albuquerque</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vassallo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelo</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joazeiro</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saad</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costa</surname>
                    <given-names>FF</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis.</article-title>
                <source>Nat Genet</source>
                <volume>38</volume>
                <fpage>807</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">16783379</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.hughan.2005.4369">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hughan</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senis</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Best</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frampton</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vyas</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watson</surname>
                    <given-names>SP</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Selective impairment of platelet activation to collagen in the absence of GATA1.</article-title>
                <source>Blood</source>
                <volume>105</volume>
                <fpage>4369</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">15701726</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.kaneko.2014.252">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaneko</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furuyama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujiwara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishida</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harigae</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shibahara</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Identification of a novel erythroid-specific enhancer for the ALAS2 gene and its loss-of-function mutation which is associated with congenital sideroblastic anemia.</article-title>
                <source>Haematologica.</source>
                <year>2014</year>
                <volume>99</volume>
                <fpage>252</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">23935018</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.klar.2014.949">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klar</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khalfallah</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arzoo</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gazda</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahl</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Recurrent GATA1 mutations in Diamond-Blackfan anaemia.</article-title>
                <source>Br J Haematol.</source>
                <volume>166</volume>
                <fpage>949</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">24766296</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.kratz.2008.432">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kratz</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niemeyer</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karow</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Volz-Fleckenstein</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmitt-Gr&#x000e4;ff</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strahm</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Congenital transfusion-dependent anemia and thrombocytopenia with myelodysplasia due to a recurrent GATA1(G208R) germline mutation.</article-title>
                <source>Leukemia</source>
                <volume>22</volume>
                <fpage>432</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">17713552</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.li.2005.613">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Godinho</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klusmann</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garriga-Canut</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orkin</surname>
                    <given-names>SH</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1.</article-title>
                <source>Nat Genet</source>
                <volume>37</volume>
                <fpage>613</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15895080</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.lindeboom.2003.5405">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lindeboom</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gillemans</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaegle</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meijer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grosveld</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philipsen</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>A tissue-specific knockout reveals that Gata1 is not essential for Sertoli cell function in the mouse.</article-title>
                <source>Nucleic Acids Research</source>
                <volume>31</volume>
                <fpage>5405</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">12954777</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.lowry.2006.6">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lowry</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>GATA-1: one protein, many partners.</article-title>
                <source>Int J Biochem Cell Biol</source>
                <volume>38</volume>
                <fpage>6</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">16095949</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.mehaffey.2001.2681">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mehaffey</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newton</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gandhi</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crossley</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drachman</surname>
                    <given-names>JG</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>X-linked thrombocytopenia caused by a novel mutation of GATA-1.</article-title>
                <source>Blood</source>
                <volume>98</volume>
                <fpage>2681</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11675338</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.muntean.2006.986">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Muntean</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ge</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taub</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crispino</surname>
                    <given-names>JD</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Transcription factor GATA-1 and Down syndrome leukemogenesis.</article-title>
                <source>Leuk Lymphoma</source>
                <volume>47</volume>
                <fpage>986</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">16840187</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.nichols.2000.266">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nichols</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crispino</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poncz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orkin</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maris</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiss</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1.</article-title>
                <source>Nat Genet</source>
                <volume>24</volume>
                <fpage>266</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">10700180</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.noris.2004.1219">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Noris</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pecci</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Bari</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Stazio</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Pumpo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ceresa</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arezzi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ambaglio</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savoia</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balduini</surname>
                    <given-names>CL</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Application of a diagnostic algorithm for inherited thrombocytopenias to 46 consecutive patients.</article-title>
                <source>Haematologica</source>
                <volume>89</volume>
                <fpage>1219</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">15477207</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.nurden.2007.21">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nurden</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nurden</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>The gray platelet syndrome: Clinical spectrum of the disease.</article-title>
                <source>Blood Rev</source>
                <volume>21</volume>
                <fpage>21</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">16442192</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.ohneda.2002.237">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohneda</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Roles of hematopoietic transcription factors GATA-1 and GATA-2 in the development of red blood cell lineage.</article-title>
                <source>Acta Haematol</source>
                <volume>108</volume>
                <fpage>237</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">12432220</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.parrella.2014.1319">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Parrella</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aspesi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quarello</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garelli</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavesi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carando</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nardi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellis</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramenghi</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dianzani</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Loss of GATA-1 full length as a cause of Diamond-Blackfan anemia phenotype.</article-title>
                <source>Pediatr Blood Cancer.</source>
                <volume>61</volume>
                <fpage>1319</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">24453067</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.phillips.2007.2618">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steensma</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulsipher</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spangrude</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kushner</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria.</article-title>
                <source>Blood</source>
                <volume>109</volume>
                <fpage>2618</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">17148589</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.phillips.2005.515a">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steensma</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spangrude</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kushner</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <article-title>Congenital erythropoietic porphyria, beta-thalassemia intermedia and thrombocytopenia due to a GATA1 mutation.</article-title>
                <source>Blood.</source>
                <year>2005</year>
                <volume>106</volume>
                <fpage>515A</fpage>
              </element-citation>
            </ref>
            <ref id="gata1.REF.raskind.2000.2262">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Raskind</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niakan</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolff</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsushita</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaughan</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stamatoyannopoulos</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watanabe</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rios</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ochs</surname>
                    <given-names>HD</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Mapping of a syndrome of X-linked thrombocytopenia with Thalassemia to band Xp11-12: further evidence of genetic heterogeneity of X-linked thrombocytopenia.</article-title>
                <source>Blood</source>
                <volume>95</volume>
                <fpage>2262</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10733494</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.roberts.2013.3908">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alford</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Juban</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richmond</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norton</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vallance</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perkins</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marchi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGowan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roy</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cowan</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anthony</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uthaya</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Curley</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rasiah</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watts</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholl</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bedford-Russell</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blumberg</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halsey</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>PW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Godambe</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweeney</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhatnagar</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goriely</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vyas</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia.</article-title>
                <source>Blood</source>
                <volume>122</volume>
                <fpage>3908</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">24021668</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.roy.2009.3">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roy</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norton</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vyas</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.</article-title>
                <source>British Journal of Haematology</source>
                <volume>147</volume>
                <fpage>3</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">19594743</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.sankaran.2012.2439">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sankaran</surname>
                    <given-names>VG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghazvinian</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Do</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiru</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vergilio</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beggs</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sieff</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orkin</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nathan</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lander</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gazda</surname>
                    <given-names>HT</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia.</article-title>
                <source>J Clin Invest</source>
                <volume>122</volume>
                <fpage>2439</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">22706301</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.singleton.2013.139">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Singleton</surname>
                    <given-names>BK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roxby</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stirling</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spring</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poole</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anstee</surname>
                    <given-names>DJ</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>A novel GATA1 mutation (Stop414Arg) in a family with the rare X-linked blood group Lu(a-b-) phenotype and mild macrothrombocytic thrombocytopenia.</article-title>
                <source>Br J Haematol</source>
                <volume>161</volume>
                <fpage>139</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">23278136</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.solis.2001.753">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Solis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aizencang</surname>
                    <given-names>GI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Astrin</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bishop</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desnick</surname>
                    <given-names>RJ</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria.</article-title>
                <source>J Clin Invest</source>
                <volume>107</volume>
                <fpage>753</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">11254675</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.thompson.1977.303">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stamatoyannopoulos</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1977</year>
                <article-title>X-linked syndrome of platelet dysfunction, thrombocytopenia, and imbalanced globin chain synthesis with hemolysis.</article-title>
                <source>Blood</source>
                <volume>50</volume>
                <fpage>303</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">871527</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.toki.2013.3181">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Toki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanezaki</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneko</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terui</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanegane</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maeda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Endo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizuochi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adachi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>E.</given-names>
                  </name>
                </person-group>
                <article-title>Naturally occurring oncogenic GATA1 mutants with internal deletions in transient abnormal myelopoiesis in Down syndrome.</article-title>
                <source>Blood</source>
                <year>2013</year>
                <volume>121</volume>
                <fpage>3181</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">23440243</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.tournamille.1995.224">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tournamille</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colin</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cartron</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Van Kim</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals.</article-title>
                <source>Nat Genet</source>
                <volume>10</volume>
                <fpage>224</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">7663520</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.tsang.1997.109">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tsang</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Visvader</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujiwara</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiss</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crossley</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orkin</surname>
                    <given-names>SH</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation.</article-title>
                <source>Cell</source>
                <volume>90</volume>
                <fpage>109</fpage>
                <lpage>19</lpage>
                <pub-id pub-id-type="pmid">9230307</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.tubman.2007.3297">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tubman</surname>
                    <given-names>VN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levine</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campagna</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleming</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neufeld</surname>
                    <given-names>EJ</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>X-linked gray platelet syndrome due to a GATA1 Arg261Gln mutation.</article-title>
                <source>Blood</source>
                <volume>109</volume>
                <fpage>3297</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17209061</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.waltzer.2003.6516">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Waltzer</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferjoux</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bataille</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haenlin</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Cooperation between the GATA and RUNX factors Serpent and Lozenge during Drosophila hematopoiesis.</article-title>
                <source>EMBO J</source>
                <volume>22</volume>
                <fpage>6516</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">14657024</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.wechsler.2002.148">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wechsler</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greene</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDevitt</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anastasi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karp</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Beau</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crispino</surname>
                    <given-names>JD</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.</article-title>
                <source>Nat Genet</source>
                <volume>32</volume>
                <fpage>148</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">12172547</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.white.2007.620">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>JG</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Platelet pathology in carriers of the X-linked GATA-1 macrothrombocytopenia.</article-title>
                <source>Platelets</source>
                <volume>18</volume>
                <fpage>620</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18041654</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.white.2007.436">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nichols</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steensma</surname>
                    <given-names>DP</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Platelet pathology in sex-linked GATA-1 dyserythropoietic macrothrombocytopenia II. Cytochemistry.</article-title>
                <source>Platelets</source>
                <volume>18</volume>
                <fpage>436</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">17763153</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.yu.2002.2040">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niakan</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsushita</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stamatoyannopoulos</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orkin</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raskind</surname>
                    <given-names>WH</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction.</article-title>
                <source>Blood</source>
                <volume>100</volume>
                <fpage>2040</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12200364</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.zucker.2016.917">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zucker</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temm</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Czader</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nalepa</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>A Child With Dyserythropoietic Anemia and Megakaryocyte Dysplasia Due to a Novel 5'UTR GATA1s Splice Mutation.</article-title>
                <source>Pediatr Blood Cancer.</source>
                <volume>63</volume>
                <fpage>917</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">26713410</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="gata1.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="gata1.Suggested_Reading.reflist0">
            <ref id="gata1.REF.balduini.2007.2770">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Balduini</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Candia</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savoia</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Why the disorder induced by GATA1 Arg216Gln mutation should be called "X-linked thrombocytopenia with thalassemia" rather than "X-linked gray platelet syndrome".</article-title>
                <source>Blood.</source>
                <volume>110</volume>
                <fpage>2770</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">17881640</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.ciovacco.2008.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ciovacco</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raskind</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kacena</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Human phenotypes associated with GATA-1 mutations.</article-title>
                <source>Gene</source>
                <volume>427</volume>
                <fpage>1</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">18930124</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.de_waele.2010.314">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Waele</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Louwette</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thys</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wittevrongel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vos</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Debeer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Geet</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Severe gastrointestinal bleeding and thrombocytopenia in a child with an anti-GATA1 autoantibody.</article-title>
                <source>Pediatr Res</source>
                <volume>67</volume>
                <fpage>314</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19924028</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.hamlett.2008.2738">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hamlett</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Draper</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strouboulis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iborra</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porcher</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vyas</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Characterization of megakaryocyte GATA1-interacting proteins: the corepressor ETO2 and GATA1 interact to regulate terminal megakaryocyte maturation.</article-title>
                <source>Blood</source>
                <volume>112</volume>
                <fpage>2738</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">18625887</pub-id>
              </element-citation>
            </ref>
            <ref id="gata1.REF.millikan.2011.682">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Millikan</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balamohan</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raskind</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kacena</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Inherited thrombocytopenia due to GATA1 mutations.</article-title>
                <source>Semin Thromb Hemost.</source>
                <volume>37</volume>
                <fpage>682</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">22102271</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="gata1.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="gata1.Author_History">
          <title>Author History</title>
          <p>Stella T Chou, MD (2006-present)Melissa A Kacena, PhD (2006-present)Jessica Kirk, BS; Yale University School of Medicine (2006-2011)Wendy H Raskind, MD, PhD (2006-present)Mitchell J Weiss, MD, PhD (2006-present)</p>
        </sec>
        <sec id="gata1.Acknowledgments">
          <title>Acknowledgments</title>
          <p>This work was supported in part by NIH grants NCRR RR025760 and RR025761 (MAK), NIH K08 HL093290 and R01 DK100854 (STC), NIH P30 DK090969 (MJW, STC), P30 DK0724429 (MAK), NIAMS R03 AR055269 (MAK), NIAMS R01 AR060332 (MAK), NIA R01 AG046246 (MAK) and by the American Society of Hematology Scholar Award (STC).</p>
        </sec>
        <sec id="gata1.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>11 May 2017 (ha) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>17 April 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>22 March 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>30 March 2007 (cd) Revision: prenatal testing clinically available</p>
            </list-item>
            <list-item>
              <p>21 February 2007 (cd) Revision: clinical testing available</p>
            </list-item>
            <list-item>
              <p>22 November 2006 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>10 August 2006 (whr) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
